The antifibrotic effect and mechanism of a novel tyrosine kinase inhibitor, ZSP1603, in preclinical models of pulmonary fibrosis.
Lists
Only you see this
Abstract
ZSP1603 is an effective anti-fibrotic compound with clear mechanisms.
BibTeX
@inproceedings{liu2020antifibrotic,
author = {Zongwen Liu and Min Zhao and Xinliang Su and Ye Tao and Yuan Zhuang and Yi Zhang and Zhongzhi Zhang and Yang Jl and Ling‐Jyh Chen and C.-F. Long and Yanli Yao and X.-X. Chen},
title = {{The antifibrotic effect and mechanism of a novel tyrosine kinase inhibitor, ZSP1603, in preclinical models of pulmonary fibrosis.}},
booktitle = {PubMed},
year = {2020},
doi = {10.26355/eurrev\_202002\_20207},
}Loading related content...